Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 866-872, February 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mutch, D. G.
Right arrow Articles by Collins, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mutch, D. G.
Right arrow Articles by Collins, J. L.

Resistance to Cytolysis by Tumor Necrosis Factor {alpha} in Malignant Gynecological Cell Lines Is Associated with the Expression of Protein(s) That Prevent the Activation of Phospholipase A2 by Tumor Necrosis Factor {alpha}

David G. Mutch1, C. Bethan Powell2, Ming-Shian Kao and John Leslie Collins3

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri 63110

Although there are a limited number of cell lines that are sensitive to cytolysis by tumor necrosis factor {alpha} (TNF{alpha}), the vast majority are resistant. The analysis of TNF{alpha}-sensitive cells has shown that phospholipase A2 is activated by TNF{alpha} in these cells and that the activity of phospholipase A2 is required for their cytolysis. Many cell lines that are resistant to TNF{alpha}-mediated cytolysis are dependent on the maintenance of protein synthesis for their resistance. We have recently shown that this is also true for TNF{alpha}-resistant cell lines derived from cervical (ME-180 and SiHa) and ovarian (SK-OV-3 and OVCAR-3) carcinomas, in that they are sensitive to cytolysis by TNF{alpha} only in the presence of protein synthesis inhibitors. Here we show that the TNF{alpha}-mediated cytolysis of these resistant cell lines in the presence of the protein synthesis inhibitor emetine is similar to that of sensitive cells, in that cytolysis is inhibited by the inhibitors of phospholipase A2. The measurement of the release of radiolabeled material from cervical and ovarian carcinoma cell lines prelabeled with [3H]arachidonic acid showed that not only was phospholipase A2 required for the cytolysis of these cells by TNF{alpha} in the presence of protein synthesis inhibitors, but more importantly, phospholipase A2 was not activated by TNF{alpha} unless protein synthesis was inhibited. These results indicate that a protein synthesis-dependent resistance mechanism expressed by these cell lines blocks TNF{alpha}-mediated cytolysis by preventing the activation of phospholipase A2 by TNF{alpha}.

1 Supported by American Cancer Society Career Development Award (1990–1993).

2 Current address: University of California at San Francisco, Division of Gynecologic Oncology, 350 Parnassus Avenue, Suite 300, San Francisco, CA 94117.

3 To whom requests for reprints should be addressed, at: Department of Obstetrics and Gynecology, Washington University School of Medicine, 4911 Barnes Hospital Plaza, St. Louis, MO 63110.

Received 4/ 8/91. Accepted 11/19/91.




This article has been cited by other articles:


Home page
J. Immunol.Home page
D. W. Draper, V. G. Harris, C. A. Culver, and S. M. Laster
Calcium and Its Role in the Nuclear Translocation and Activation of Cytosolic Phospholipase A2 in Cells Rendered Sensitive to TNF-Induced Apoptosis by Cycloheximide
J. Immunol., February 15, 2004; 172(4): 2416 - 2423.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
K. Kramer, E. O. Harrington, Q. Lu, R. Bellas, J. Newton, K. L. Sheahan, and S. Rounds
Isoprenylcysteine Carboxyl Methyltransferase Activity Modulates Endothelial Cell Apoptosis
Mol. Biol. Cell, March 1, 2003; 14(3): 848 - 857.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y.-L. Wu, X.-R. Jiang, A. C. Newland, and S. M. Kelsey
Failure to Activate Cytosolic Phospholipase A2 Causes TNF Resistance in Human Leukemic Cells
J. Immunol., June 15, 1998; 160(12): 5929 - 5935.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Wissing, H. Mouritzen, M. Egeblad, G. G. Poirier, and M. Jaattela
Involvement of caspase-dependent activation of cytosolic phospholipase A2 in tumor necrosis factor-induced apoptosis
PNAS, May 13, 1997; 94(10): 5073 - 5077.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Cai, A. Bettaieb, N. E. Mahdani, L. G. Legres, R. Stancou, J. Masliah, and S. Chouaib
Alteration of the Sphingomyelin/Ceramide Pathway Is Associated with Resistance of Human Breast Carcinoma MCF7 Cells to Tumor Necrosis Factor-alpha -mediated Cytotoxicity
J. Biol. Chem., March 14, 1997; 272(11): 6918 - 6926.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Scorrano, D. Penzo, V. Petronilli, F. Pagano, and P. Bernardi
Arachidonic Acid Causes Cell Death through the Mitochondrial Permeability Transition. IMPLICATIONS FOR TUMOR NECROSIS FACTOR-alpha APOPTOTIC SIGNALING
J. Biol. Chem., April 6, 2001; 276(15): 12035 - 12040.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.